 NEW YORK, March 09, 2021 GLOBE NEWSWIRE -- Checkpoint Therapeutics, Inc. Checkpoint NASDAQ: CKPT, a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the full-year ended December 31, 2020 and recent corporate highlights. 